Form 4 for RNXT RenovoRx, Inc.
Accepted 2026-01-02 00:00:00 ET · period of report 2025-12-30 · accession 0001493152-26-000157 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-01-02 | 2025-12-30 | RNXT | Agah Ramtin | Chief Medical Off, Dir | P - Purchase | $0.83 | +205 | 778.7K | +0.0% | +$170.15 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-30 | P | A | 205 | $0.83 | 778,665 | D | — | — | (F1) Reflects open market purchases of the Issuer's securities. (F2) Reflects a weighted average price. The securities were purchased in multiple transactions at per share prices ranging from $0.825 to $0.873. |